| Literature DB >> 32211434 |
Sarah J Wahltinez1, Alisa L Newton2, Craig A Harms3, Lesanna L Lahner4, Nicole I Stacy1.
Abstract
Sea Star Wasting Syndrome (SSWS) is one of the largest marine wildlife die-offs ever recorded, killing millions of sea stars from more than 20 Asteroid species from Alaska to Mexico from 2013 to 2015 from yet undetermined cause(s). Coelomic fluid surrounds the sea star's organs, playing critical roles in numerous systemic processes, including nutrient transportation and immune functions. Coelomocytes, which are cellular components of coelomic fluid and considered functionally equivalent to vertebrate leukocytes, are responsible for innate cell-mediated immunity. The objectives of this study were to (1) evaluate changes in coelomic fluid chemistry, coelomocyte counts, and cytology from ochre sea stars (Pisaster ochraceus) (n = 55) with clinical signs consistent with SSWS at varying intensity (SSWS score 1: n = 4, score 2: n = 2, score 3: n = 3, score 4: n = 18, score 5: n = 26) in comparison to coelomic fluid from clinically normal sea stars (n = 26) and to (2) correlate SSWS score with cellular and biochemical analytes. SSWS-affected sea stars had wider ranges of all electrolytes, except calcium; statistically significantly higher chloride, osmolality, and total protein; lower calcium; and higher coelomocyte counts when compared to clinically normal sea stars maintained under identical environmental conditions. Free and/or phagocytized bacteria were noted in 29% (16 of 55) coelomic fluid samples from SSWS-affected sea stars but were absent in clinically normal sea stars. SSWS score correlated significantly with increasing chloride concentration, osmolality, and coelomocyte counts. These chemistry and cytological findings in coelomic fluid of SSWS-affected sea stars provide insight into the pathophysiology of SSWS as these results suggest osmo- and calcium dysregulation, coelomocyte responses, and presumptive opportunistic bacterial infection in SSWS-affected sea stars. This information provides potential future research applications for the development of treatment strategies for sea stars in managed care and for understanding the complexity of various biochemical and cellular pathophysiological mechanisms involved in sea star wasting.Entities:
Keywords: chemistry; cytology; echinoderm disease; invertebrate; ochre sea star; osmolality
Year: 2020 PMID: 32211434 PMCID: PMC7069445 DOI: 10.3389/fvets.2020.00131
Source DB: PubMed Journal: Front Vet Sci ISSN: 2297-1769
Clinical observations based on a 1–5 grading scale in sea stars affected by Sea Star Wasting Syndrome, adapted from Bates et al. (19).
| 0 | Clinically normal |
| 1 | Mild disease, no white lesions; often central disc flattening, lack of adherence to substrate, mild swelling of arms, and abnormal wrapping of arms at rest |
| 2 | Mild disease with small white lesions restricted to one arm or only the central disc |
| 3 | Moderate disease with white lesions on one arm plus the central disc OR two arms OR an arm/disc interface |
| 4 | Severe disease; white lesions on three or more arms OR two arms plus central disc OR arm/disc interface plus arm or central disc OR more than one arm/disc interface lesion |
| 5 | Severe disease; one or more arms detached from the central disc OR non-responsive, detached from substrate and lacking tube foot movement |
Figure 1Box plots comparing coelomic fluid chemistry data (A–F), osmolality (G), and coelomocyte counts (H) of Pisaster ochraceus showing clinical signs consistent with Sea Star Wasting Syndrome compared to clinically normal P. ochraceus. *Denotes statistical significance (P < 0.05).
Coelomic fluid chemistry data and coelomocyte counts of Pisaster ochraceus showing clinical signs consistent with Sea Star Wasting Syndrome.
| Magnesium | mmol/L | 41 | 46 | 7.5 | 48 | 16–54 | 43–53 |
| Sodium | mmol/L | 41 | 412 | 15.8 | 407 | 381–463 | 396–442 |
| Potassium | mmol/L | 41 | 8.8 | 1.9 | 8.2 | 7.8–19.1 | 8.0–9.0 |
| Chloride | mmol/L | 39 | 473 | 25.7 | 479 | 427–553 | 416–461 |
| Calcium | mmol/L | 41 | 8.7 | 1.0 | 8.9 | 4.2–10.3 | 7.4–13.7 |
| Total Protein | g/L | 38 | 21 | 69.6 | 20 | <10–50 | Range: <10–20 |
| Coelomocytes | 55 | 6126 | 12393.1 | 900 | 0–60,750 | Range: 0–180 | |
| Osmolality | mOsm/kgH2O | 8 | 875 | 4.3 | 875 | 870–882 | NA |
CI, Confidence Interval for clinically normal sea stars*; NA, not available.
Wahltinez et al. (.
Number of cells.
Figure 2Image composite of coelomic fluid sediment smear preparations from ochre sea stars (Pisaster ochraceus) affected by Sea Star Wasting Syndrome. (A) Presumptive salt crystal (black arrowhead) and mononuclear phagocyte morphotype cells showing variable vacuolation. (B) Presumptive cholesterol crystals (one example shown by white arrowhead) and two presumptive salt crystals (black arrowheads). (C) Extracellular and phagocytized bacilli (white arrowheads) in close association with mononuclear phagocyte morphotype cells. (D) Mononuclear phagocyte morphotype cells with variable amounts of phagocytized material of undetermined origin. (E,F) Two mononuclear phagocyte morphotype cells with phagocytized small bacilli (white arrowheads). Scale bars = 10 μm.
Figure 3Correlation plots comparing coelomic fluid chemistry data (A–F), osmolality (G), and coelomocyte counts (H) of Pisaster ochraceus showing clinical signs consistent with Sea Star Wasting Syndrome (SSWS) compared with clinically normal P. ochraceus grouped by SSWS Score (0–5). *Denotes statistical significance (P < 0.05).